Peginterferon alfa-2b biosimilar (Fiocruz)

聚乙二醇干扰素α-2b生物类似药 (Fiocruz)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2b biosimilar (Fiocruz)
Drug Alias Name聚乙二醇干扰素α-2b生物仿制药 (Fiocruz)BIP-48
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeL03AB10
Related LinksN/A